BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26177318)

  • 1. C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.
    Baloch ZW; LiVolsi VA
    Turk Patoloji Derg; 2015; 31 Suppl 1():60-79. PubMed ID: 26177318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C Cell and Follicular Epithelial Cell Precursor Lesions of the Thyroid.
    Scognamiglio T
    Arch Pathol Lab Med; 2017 Dec; 141(12):1646-1652. PubMed ID: 28644684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of cytomorphology of medullary thyroid carcinomas between family members with the same RET proto-oncogene mutation.
    Chang JS; Chang CF; Yang WS; Chang TC
    Acta Cytol; 2011; 55(6):556-62. PubMed ID: 22156466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the Significance of Prominent C Cells in the Thyroid.
    Fuchs TL; Bell SE; Chou A; Gill AJ
    Endocr Pathol; 2019 Jun; 30(2):113-117. PubMed ID: 30694510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-cell hyperplasia and medullary thyroid microcarcinoma.
    Albores-Saavedra JA; Krueger JE
    Endocr Pathol; 2001; 12(4):365-77. PubMed ID: 11914470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medullary thyroid cancer - the present state of art].
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2008; 59(5):446-55. PubMed ID: 18979455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.
    Perry A; Molberg K; Albores-Saavedra J
    Cancer; 1996 Feb; 77(4):750-6. PubMed ID: 8616768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
    Ting S; Synoracki S; Schmid KW
    Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
    Wells SA; Asa SL; Dralle H; Elisei R; Evans DB; Gagel RF; Lee N; Machens A; Moley JF; Pacini F; Raue F; Frank-Raue K; Robinson B; Rosenthal MS; Santoro M; Schlumberger M; Shah M; Waguespack SG;
    Thyroid; 2015 Jun; 25(6):567-610. PubMed ID: 25810047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of medullary carcinoma of the thyroid during pregnancy in a patient with an intron substitution.
    Walshe P; Seaberg RM; Yehuda M; Freeman J
    J Otolaryngol Head Neck Surg; 2008 Apr; 37(2):E39-41. PubMed ID: 19137655
    [No Abstract]   [Full Text] [Related]  

  • 13. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
    Marsh DJ; Andrew SD; Eng C; Learoyd DL; Capes AG; Pojer R; Richardson AL; Houghton C; Mulligan LM; Ponder BA; Robinson BG
    Cancer Res; 1996 Mar; 56(6):1241-3. PubMed ID: 8640806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different outcomes in sporadic versus familial medullary thyroid cancer.
    Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
    Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of FoxA1 expression in thyroid tumors.
    Nonaka D
    Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 2.
    Lodish M
    Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of clinical, histopathological and immunohistochemical features in medullary thyroid cancer].
    Ríos A; Rodríguez JM; Febrero B; Acosta JM; Torregrosa N; Parrilla P
    Med Clin (Barc); 2012 Sep; 139(7):277-83. PubMed ID: 22032817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.
    Toledo RA; Maciel RM; Erlic Z; Lourenço DM; Cerutti JM; Eng C; Neumann HP; Toledo SP
    Thyroid; 2015 Aug; 25(8):973-4. PubMed ID: 25950813
    [No Abstract]   [Full Text] [Related]  

  • 20. Medullary thyroid cancer.
    Moley JF
    Surg Clin North Am; 1995 Jun; 75(3):405-20. PubMed ID: 7747249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.